• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用锝-99m亚甲基二膦酸盐(Tc-99m MDP)和锝-99m柠檬酸盐闪烁扫描法鉴别恶性与退行性良性骨病

Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.

作者信息

Sharma R, Mondal A, Bhatnagar A, Chakravarty K L, Mishra P, Chopra M K, Rawat H S, Kashyap R

机构信息

Department of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Delhi, India.

出版信息

Clin Nucl Med. 1998 Nov;23(11):758-63. doi: 10.1097/00003072-199811000-00008.

DOI:10.1097/00003072-199811000-00008
PMID:9814564
Abstract

The authors present a prospective analysis of Tc-99m MDP and Tc-99m citrate scintigraphy in 108 patients with known malignant or degenerative benign bone disease. Of 108 patients, 59 (group A) had malignant bone disease. The other 49 patients (group B) had degenerative benign bone disease for which the results of Tc-99m MDP scans were positive. In both groups the Tc-99m citrate scan was performed 1 week after the Tc-99m MDP scan. The Tc-99m citrate/Tc-99m MDP lesion-to-background radioisotope uptake ratio (RUR) was calculated for each lesion 3 hours after radionuclide administration. The mean RUR for the malignant lesions was 1.0 +/- 0.484; for the benign lesions, the RUR was 0.29 +/- 0.250. Static imaging was also done for 10 lesions each from the malignant and benign groups at 1, 3, and 24 hours to study the kinetics of Tc-99m citrate. Time-activity curves for malignant lesions showed that the RUR remained high for 24 hours, whereas benign lesions showed a drastic decrease at 3 and 24 hours compared with the 1-hour images. The ratio of Tc-99m citrate to Tc-99m MDP is a promising parameter to differentiate malignant from benign degenerative lesions seen as areas of increased activity on Tc-99m MDP bone scans. The sensitivity and specificity of this technique were 97.8% and 95%, respectively.

摘要

作者对108例已知患有恶性或退行性良性骨病的患者进行了锝-99m亚甲基二膦酸盐(Tc-99m MDP)和锝-99m枸橼酸盐闪烁扫描的前瞻性分析。108例患者中,59例(A组)患有恶性骨病。另外49例患者(B组)患有退行性良性骨病,其Tc-99m MDP扫描结果为阳性。两组均在Tc-99m MDP扫描1周后进行Tc-99m枸橼酸盐扫描。在放射性核素给药3小时后,计算每个病灶的Tc-99m枸橼酸盐/Tc-99m MDP病灶与本底放射性同位素摄取比(RUR)。恶性病灶的平均RUR为1.0±0.484;良性病灶的RUR为0.29±0.250。还对恶性和良性组各10个病灶在1、3和24小时进行了静态成像,以研究Tc-99m枸橼酸盐的动力学。恶性病灶的时间-活性曲线显示,RUR在24小时内保持较高水平,而良性病灶在3小时和24小时时与1小时图像相比急剧下降。Tc-99m枸橼酸盐与Tc-99m MDP的比值是区分Tc-99m MDP骨扫描上表现为活性增加区域的恶性与良性退行性病灶的一个有前景的参数。该技术的敏感性和特异性分别为97.8%和95%。

相似文献

1
Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.利用锝-99m亚甲基二膦酸盐(Tc-99m MDP)和锝-99m柠檬酸盐闪烁扫描法鉴别恶性与退行性良性骨病
Clin Nucl Med. 1998 Nov;23(11):758-63. doi: 10.1097/00003072-199811000-00008.
2
Differentiation of malignant and degenerative bone lesions using dexamethasone interventional 3- and 24-hour bone scintigraphy.
Eur J Nucl Med. 1994 Jul;21(7):609-14. doi: 10.1007/BF00285582.
3
99Tcm-citrate: a new bone imaging radiopharmaceutical.锝-99m柠檬酸盐:一种新型骨显像放射性药物。
Nucl Med Commun. 1999 Nov;20(11):1067-76.
4
Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.锝-99m-甲氧基异丁基异腈在良性和恶性骨病变中的摄取:与锝-99m-亚甲基二膦酸盐的对比研究。
J Nucl Med. 1992 Mar;33(3):319-24.
5
24 hour/3 hour radio-uptake technique for differentiating degenerative and malignant bony lesions in bone scanning.
Australas Radiol. 1993 May;37(2):198-200. doi: 10.1111/j.1440-1673.1993.tb00050.x.
6
The value of Tc-99m citrate scintigraphy in chronic osteomyelitis. An indicator of the involved bone.
Clin Nucl Med. 1995 Aug;20(8):712-6. doi: 10.1097/00003072-199508000-00012.
7
Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.用五价99锝(m)-二巯基丁二酸评估转移性骨病:与全身扫描及椎体病变4/24小时定量分析的比较
Nucl Med Commun. 2000 Mar;21(3):251-8. doi: 10.1097/00006231-200003000-00009.
8
Accurate characterization of Tc-MDP uptake in extraosseous neoplasm mimicking bone metastasis on whole-body bone scan: contribution of SPECT/CT.准确描述全身骨扫描中骨转移瘤样的骨外肿瘤摄取 Tc-MDP:SPECT/CT 的作用。
BMC Med Imaging. 2019 May 30;19(1):44. doi: 10.1186/s12880-019-0345-1.
9
[Preliminary application of 99Tc(m)-MIBI scintigraphy for judgment of bone malignant and benign lesions].99Tc(m)-甲氧基异丁基异腈闪烁显像在骨良恶性病变判断中的初步应用
Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Jul;38(4):689-92.
10
Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot.锝-99m亚甲基二膦酸盐、锝-99m人免疫球蛋白和锝-99m标记的白细胞闪烁扫描术在糖尿病足中的比较。
Clin Nucl Med. 2001 Dec;26(12):1016-21. doi: 10.1097/00003072-200112000-00005.